Clinical Study

CORDIART provides triple heart protection

Published

Format: PDF file | Document type: Clinical Study

CORDIART provides triple heart protection

The benefits of CORDIART, a natural rutinoside extract, on the maintenance of a good cardiovascular health have been assessed in several clinical studies. A newly completed clinical study further underpins CORDIART’s triple action: 1) maintenance of endothelial flexibility, 2) reduction of plaques formation, 3) improved control of platelet activation and adhesion molecules.

If you want to have more information about CORDIART, contact us (info@bioactor.com) or have a look at www.cordiart.com.

Related resources from BioActor

Show more

Supplier info centre